IQOS 3.0 Authorized for Sale in the U.S.

IQOS 3.0 Authorized for Sale in the U.S. Fantastic news for American IQOS users! The United States Food and Drug Administration (FDA) announced Monday that it has authorized the sale of IQOS 3.0 in the U.S. In 2019, the FDA authorized several IQOS products for sale, however only one device was included in that; IQOS 2.4, an older IQOS model. Nearly one year later, in March of 2020, Philip Morris International (PMI) filed a Premarket Tobacco Product Application (PMTA) for IQOS 3.0. An FDA... Read more

HEETS vs. Marlboro for IQOS

HEETS vs. Marlboro for IQOS What's the Difference Between HEETS and Marlboro for IQOS? When talking about Heat-not-Burn HeatSticks are an essential part of the conversation. Two of the most well-known HeatStick lines are HEETS and Marlboro for IQOS. Both of these lines are manufactured by big tobacco giant Philip Morris International and are specially designed to work with IQOS (although they work with most other Heat-not-Burn devices as well). So what is the difference between HEETS and... Read more

Learn More About FDA Ruling that IQOS is Modified Risk

Learn More About FDA Ruling that IQOS is Modified Risk It took more than 3 years for the United States Food and Drug Administration (FDA) to complete their review of IQOS and determine whether it would be considered a modified risk tobacco product (MTRP). Today Philip Morris International (PMI), the maker of IQOS, released a comprehensive overview of that review process, including a detailed examination of legal requirements and assessment tools like studies and post-market surveillance. To... Read more

PMI Releases 2020 Second-Quarter Report

PMI Releases 2020 Second-Quarter Report On July 21, 2020, Philip Morris International (PMI), the maker of IQOS, released its 2020 Second Quarter report. HIGHLIGHTS Net revenue decreased by 13.6% Operating profits decreased by 14.3% The report states that "PMI does not currently anticipate out-of-stock situations in any major operating income markets and generally expects consumers to have adequate access to its products" IQOS HIGHLIGHTS Market share for IQOS rose by 1.8 points... Read more

FDA Allows IQOS to be Marketed as Reduced-Risk

FDA Allows IQOS to be Marketed as Reduced-Risk TODAY'S RULING Another huge victory for Heat-not-Burn and harm reduction, as today the United States Food and Drug Administration (FDA) authorized the marketing of IQOS as a modified-risk tobacco product (MRTP). MRTP are tobacco products that are deemed to  pose "significantly lower risks to individual users and benefits the population as a whole." So what today's ruling means is that, within the United States, IQOS can now be marketed as less... Read more

FDA Authorizes IQOS for Sale in the USA

FDA Authorizes IQOS for Sale in the USA Did you hear the news? IQOS will soon be available in the US! The US Food and Drug Administration announced on April 30th, that they have authorized IQOS for sale across America. This decision comes after a nearly two-year wait during which IQOS technology underwent a scientific review process in what is known as the premarket tobacco product application (PMTA). "The [...] evaluation includes reviewing a tobacco product’s components, ingredients,... Read more